Topic: Drug Production

Donald Trump invoked the Defense Production Act for the 33rd time to grant Kodak a $765 million loan to produce generic drug ingredients in the United States. The deal aims to bring 25% of active pharmaceutical ingredient manufacturing back to domestic soil, specifically focusing on materials for hydroxychloroquine. Kodak's stock price surged significantly prior to the official announcement, raising concerns about potential insider trading.

The Afghan Minister of Counter-Narcotics alleged that foreign NATO troops are profiting from drug production within the regions they control. The report claims that military forces are effectively taxing opium production rather than eradicating it. This behavior is compared to historical imperial strategies of resource extraction and local exploitation.

The war in Afghanistan is described as a long-term conflict that may last another 15 years. The hosts examine the influence of President Hamid Karzai's brothers, Mahmoud and Ahmed Wali Karzai, who reportedly control the country's cement industry, Toyota dealerships, and the opium drug trade while being protected by coalition forces.